WHO Report Reveals Tuberculosis as 2023’s Deadliest Infectious Disease 29/10/2024 Maayan Hoffman Shaka Brown was diagnosed with tuberculosis (TB) in November 2023. “I was dropped off at the emergency room in Miami, Florida,” he recalled. “In September, I thought I’d caught the flu, but after weeks of night sweats, fainting spells, and losing my hearing in my left ear—and over 50 pounds—I knew something was wrong.” Brown […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> WHO Recommends Three Shorter, Oral Treatments for Drug-Resistant TB 22/08/2024 Kerry Cullinan The World Health Organization (WHO) this week recommended three new regimens for multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) tuberculosis (TB) that are far shorter than the current regimens and can be taken orally. The new regimens can cure patients in six to nine months rather than the usual 18 months and dispense with the painful injections […] Continue reading -> Positioning the University of Ghana as a ‘Research-Intensive’ Institution on Neglected Diseases 03/07/2024 Jessica Ahedor Almost 15 years ago, when the University of Ghana established its Office of Research, Innovation, and Development, it did so with the goal of bolstering the West African nation’s research capacity. In the African region, where less than 0.5% of GDP is devoted to research, and a significant number of Africa’s educated is siphoned off […] Continue reading -> Should Global Health Initiatives Have a Termination Date? 07/06/2024 Sophia Samantaroy One of the world’s largest global health initiatives (GHI), vaccine alliance Gavi, started in a UNICEF basement with a staff of five people. Nearly 25 years later, Gavi has grown into one of the most influential players on the global health stage, driving progress on key global health challenges. Yet several experts on global health […] Continue reading -> New Technology Enables Philippines to Bring Tuberculosis Diagnosis Closer to People 25/03/2024 James Cruz A woman walks to an open tent and stands before a “camera” on a tripod, with a green curtain serving as her backdrop. “One, two, three…hold still…deep breath,” instructs the man in a black vest, speaking in Filipino, then presses the shutter. Within five minutes, the photo is ready. But this is no ordinary snapshot […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> Trial Finds Four New Treatment Options for Multi-Drug Resistant Tuberculosis 16/11/2023 Kerry Cullinan Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> WHO Recommends Three Shorter, Oral Treatments for Drug-Resistant TB 22/08/2024 Kerry Cullinan The World Health Organization (WHO) this week recommended three new regimens for multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) tuberculosis (TB) that are far shorter than the current regimens and can be taken orally. The new regimens can cure patients in six to nine months rather than the usual 18 months and dispense with the painful injections […] Continue reading -> Positioning the University of Ghana as a ‘Research-Intensive’ Institution on Neglected Diseases 03/07/2024 Jessica Ahedor Almost 15 years ago, when the University of Ghana established its Office of Research, Innovation, and Development, it did so with the goal of bolstering the West African nation’s research capacity. In the African region, where less than 0.5% of GDP is devoted to research, and a significant number of Africa’s educated is siphoned off […] Continue reading -> Should Global Health Initiatives Have a Termination Date? 07/06/2024 Sophia Samantaroy One of the world’s largest global health initiatives (GHI), vaccine alliance Gavi, started in a UNICEF basement with a staff of five people. Nearly 25 years later, Gavi has grown into one of the most influential players on the global health stage, driving progress on key global health challenges. Yet several experts on global health […] Continue reading -> New Technology Enables Philippines to Bring Tuberculosis Diagnosis Closer to People 25/03/2024 James Cruz A woman walks to an open tent and stands before a “camera” on a tripod, with a green curtain serving as her backdrop. “One, two, three…hold still…deep breath,” instructs the man in a black vest, speaking in Filipino, then presses the shutter. Within five minutes, the photo is ready. But this is no ordinary snapshot […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> Trial Finds Four New Treatment Options for Multi-Drug Resistant Tuberculosis 16/11/2023 Kerry Cullinan Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Recommends Three Shorter, Oral Treatments for Drug-Resistant TB 22/08/2024 Kerry Cullinan The World Health Organization (WHO) this week recommended three new regimens for multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) tuberculosis (TB) that are far shorter than the current regimens and can be taken orally. The new regimens can cure patients in six to nine months rather than the usual 18 months and dispense with the painful injections […] Continue reading -> Positioning the University of Ghana as a ‘Research-Intensive’ Institution on Neglected Diseases 03/07/2024 Jessica Ahedor Almost 15 years ago, when the University of Ghana established its Office of Research, Innovation, and Development, it did so with the goal of bolstering the West African nation’s research capacity. In the African region, where less than 0.5% of GDP is devoted to research, and a significant number of Africa’s educated is siphoned off […] Continue reading -> Should Global Health Initiatives Have a Termination Date? 07/06/2024 Sophia Samantaroy One of the world’s largest global health initiatives (GHI), vaccine alliance Gavi, started in a UNICEF basement with a staff of five people. Nearly 25 years later, Gavi has grown into one of the most influential players on the global health stage, driving progress on key global health challenges. Yet several experts on global health […] Continue reading -> New Technology Enables Philippines to Bring Tuberculosis Diagnosis Closer to People 25/03/2024 James Cruz A woman walks to an open tent and stands before a “camera” on a tripod, with a green curtain serving as her backdrop. “One, two, three…hold still…deep breath,” instructs the man in a black vest, speaking in Filipino, then presses the shutter. Within five minutes, the photo is ready. But this is no ordinary snapshot […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> Trial Finds Four New Treatment Options for Multi-Drug Resistant Tuberculosis 16/11/2023 Kerry Cullinan Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Positioning the University of Ghana as a ‘Research-Intensive’ Institution on Neglected Diseases 03/07/2024 Jessica Ahedor Almost 15 years ago, when the University of Ghana established its Office of Research, Innovation, and Development, it did so with the goal of bolstering the West African nation’s research capacity. In the African region, where less than 0.5% of GDP is devoted to research, and a significant number of Africa’s educated is siphoned off […] Continue reading -> Should Global Health Initiatives Have a Termination Date? 07/06/2024 Sophia Samantaroy One of the world’s largest global health initiatives (GHI), vaccine alliance Gavi, started in a UNICEF basement with a staff of five people. Nearly 25 years later, Gavi has grown into one of the most influential players on the global health stage, driving progress on key global health challenges. Yet several experts on global health […] Continue reading -> New Technology Enables Philippines to Bring Tuberculosis Diagnosis Closer to People 25/03/2024 James Cruz A woman walks to an open tent and stands before a “camera” on a tripod, with a green curtain serving as her backdrop. “One, two, three…hold still…deep breath,” instructs the man in a black vest, speaking in Filipino, then presses the shutter. Within five minutes, the photo is ready. But this is no ordinary snapshot […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> Trial Finds Four New Treatment Options for Multi-Drug Resistant Tuberculosis 16/11/2023 Kerry Cullinan Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Should Global Health Initiatives Have a Termination Date? 07/06/2024 Sophia Samantaroy One of the world’s largest global health initiatives (GHI), vaccine alliance Gavi, started in a UNICEF basement with a staff of five people. Nearly 25 years later, Gavi has grown into one of the most influential players on the global health stage, driving progress on key global health challenges. Yet several experts on global health […] Continue reading -> New Technology Enables Philippines to Bring Tuberculosis Diagnosis Closer to People 25/03/2024 James Cruz A woman walks to an open tent and stands before a “camera” on a tripod, with a green curtain serving as her backdrop. “One, two, three…hold still…deep breath,” instructs the man in a black vest, speaking in Filipino, then presses the shutter. Within five minutes, the photo is ready. But this is no ordinary snapshot […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> Trial Finds Four New Treatment Options for Multi-Drug Resistant Tuberculosis 16/11/2023 Kerry Cullinan Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Technology Enables Philippines to Bring Tuberculosis Diagnosis Closer to People 25/03/2024 James Cruz A woman walks to an open tent and stands before a “camera” on a tripod, with a green curtain serving as her backdrop. “One, two, three…hold still…deep breath,” instructs the man in a black vest, speaking in Filipino, then presses the shutter. Within five minutes, the photo is ready. But this is no ordinary snapshot […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> Trial Finds Four New Treatment Options for Multi-Drug Resistant Tuberculosis 16/11/2023 Kerry Cullinan Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> Trial Finds Four New Treatment Options for Multi-Drug Resistant Tuberculosis 16/11/2023 Kerry Cullinan Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> Trial Finds Four New Treatment Options for Multi-Drug Resistant Tuberculosis 16/11/2023 Kerry Cullinan Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> Trial Finds Four New Treatment Options for Multi-Drug Resistant Tuberculosis 16/11/2023 Kerry Cullinan Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Trial Finds Four New Treatment Options for Multi-Drug Resistant Tuberculosis 16/11/2023 Kerry Cullinan Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments […] Continue reading -> Posts navigation Older postsNewer posts